These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Metabolism, Pharmacokinetics, and Pharmacodynamics of Drugs of Abuse. Proceedings of a meeting. November 4-5, 1994. NIDA Res Monogr; 1997; 173():1-304. PubMed ID: 9297130 [No Abstract] [Full Text] [Related]
43. Drug dependence and addiction, III: Expectation and brain function in drug abuse. Volkow N Am J Psychiatry; 2004 Apr; 161(4):621. PubMed ID: 15056504 [No Abstract] [Full Text] [Related]
44. [Neurobiological basis of drug addiction]. Fernández-Espejo E Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517 [TBL] [Abstract][Full Text] [Related]
45. Adolescent abuse of other drugs. Greene JP; Ahrendt D; Stafford EM Adolesc Med Clin; 2006 Jun; 17(2):283-318. PubMed ID: 16814695 [TBL] [Abstract][Full Text] [Related]
46. Pharmacology of drugs of abuse. Reynolds EW; Bada HS Obstet Gynecol Clin North Am; 2003 Sep; 30(3):501-22. PubMed ID: 14664324 [TBL] [Abstract][Full Text] [Related]
47. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Payer D; Balasubramaniam G; Boileau I Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545 [TBL] [Abstract][Full Text] [Related]
48. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography. Dalley JW; Fryer TD; Aigbirhio FI; Brichard L; Richards HK; Hong YT; Baron JC; Everitt BJ; Robbins TW Neuropharmacology; 2009; 56 Suppl 1():9-17. PubMed ID: 18614184 [TBL] [Abstract][Full Text] [Related]
49. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Tassin JP Biochem Pharmacol; 2008 Jan; 75(1):85-97. PubMed ID: 17686465 [TBL] [Abstract][Full Text] [Related]
50. Drug screening in the workplace: use, abuse and implications. Grabowski J; Silverman PB NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968 [No Abstract] [Full Text] [Related]
52. Neuroreceptor mapping with in-vivo imaging techniques: principles and applications. Busatto GF; Pilowsky LS Br J Hosp Med; 1995 Apr 5-18; 53(7):309-13. PubMed ID: 7788065 [TBL] [Abstract][Full Text] [Related]
53. Positron emission tomography in studies of drug abuse. London ED NIDA Res Monogr; 1994; 138():15-24. PubMed ID: 7603540 [No Abstract] [Full Text] [Related]
54. Positron Emission Tomography: Updates on Imaging of Addiction. Solingapuram Sai JKK; Hurley RA; Dodda M; Taber KH J Neuropsychiatry Clin Neurosci; 2019; 31(4):A6-288. PubMed ID: 31613195 [No Abstract] [Full Text] [Related]
55. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Nader MA Prog Brain Res; 2016; 224():3-24. PubMed ID: 26822351 [TBL] [Abstract][Full Text] [Related]
56. PET evaluation of the dopamine system of the human brain. Volkow ND; Fowler JS; Gatley SJ; Logan J; Wang GJ; Ding YS; Dewey S J Nucl Med; 1996 Jul; 37(7):1242-56. PubMed ID: 8965206 [TBL] [Abstract][Full Text] [Related]
57. Experimental protocols for behavioral imaging: seeing animal models of drug abuse in a new light. Aarons AR; Talan A; Schiffer WK Curr Top Behav Neurosci; 2012; 11():93-115. PubMed ID: 22411423 [TBL] [Abstract][Full Text] [Related]
59. Psychoactive drug abuse in older adults. Simoni-Wastila L; Yang HK Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542 [TBL] [Abstract][Full Text] [Related]
60. A behavioral/systems approach to the neuroscience of drug addiction. White FJ J Neurosci; 2002 May; 22(9):3303-5. PubMed ID: 11978803 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]